Brigham and Women's HospitaL
Boston, Massachusetts, 02115, United States
NCT Number: NCT05062343
The goal of this study is to compare Cook balloon and Dilapan-S for outpatient cervical ripening to see if Dilapan-S is non-inferior in increasing Bishop score compared to the Cook balloon.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
Upon presentation for cervical ripening appointment, a sterile vaginal exam will be completed to assign Bishop score, as per standard routine. Once the patient has been consented and randomized, the participant will have a Cook catheter or Dilapan-S inserted. For the Cook catheter, the uterine component of the balloon will be inflated to maximum 60mL, the vaginal balloon will not be inflated per standard practice and per the literature that shows slightly increased pain and negligible improvement in cervical ripening. The catheter will be taped to the inner thigh with gentle traction. For Dilapan-S, 3-5 dilators will be placed.
After placement, the patient will be discharged home with strict return precautions per the outpatient cervical ripening protocol. Patients must return to labor and delivery within 24 hours of cervical ripening agent placement at their scheduled inpatient induction time.
Upon return to labor and delivery, if not already expelled, the mechanical ripening device will be removed, and an examiner blinded to the cervical ripening method will complete a sterile vaginal exam to assign a Bishop score.
At that point health care providers will manage active labor per usual practice. Labor interventions are at the discretion of the healthcare provider. The need for operative delivery or cesarean section will be at the discretion of the healthcare provider.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Osmotic dilator
Double balloon catheter for cervical ripening
Other names: Cook catheter
Time frame: Up to 24 hours
Difference in Bishop score calculated from exam at time of device removal minus Bishop score calculated from exam at time of device placement. Bishop score, or cervical score, ranges from a minimum of 0 to maximum of 13. Higher scores indicate that the cervix is more favorable, or ready for labor. Thus, change in Bishop score could range from -13 to +13 with a higher number showing more change in the score, or more cervical ripening.
Time frame: Assessed upon device removal, within 24 hours
Patient Satisfaction score based on patient survey. Range from 0 (unsatisfied) to 10 (highly satisfied).
Time frame: Assessed at the time of delivery, within 1 week
Mode of delivery, vaginal (including spontaneous vaginal, forceps and vacuum) and cesarean delivery
Time frame: Assessed at the time of delivery, within 1 week
Time from admission on labor and delivery until delivery. Measured in hours.
Time frame: Assessed at end of study period (week 4)
Admission Date/Time to Discharge Date/Time
Time frame: Assessed at the time of device removal, within 24 hours
Failure defined by: inability to place intervention agent or need for further cervical ripening after removal
Time frame: Assessed at end of study period (week 4)
Morbidity defined as any one of the following: higher-order laceration, blood transfusion, endometritis, wound infection, venous thromboembolism, hysterectomy, ICU admission or death
Time frame: Assessed at end of study period (week 4)
Morbidity defined as any one of the following: culture-proven neonatal sepsis, neonatal blood transfusion, hypoxic-ischemic encephalopathy, intraventricular hemorrhage grade 3 or 4, or therapeutic hypothermia
Brigham and Women's Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05671224
Induced; Birth
St Louis, Missouri, United States
View Trial DetailsNCT06623175
Acupuncture, Cervical Ripening
Modena, Italy
View Trial DetailsNCT03670836
Induced; Birth, Labor Onset and Length Abnormalities
New York, United States
View Trial DetailsNCT06272591
Induced; Birth, Pregnancy
Saint-Etienne, France
View Trial Details